LOOK AT THE BLOG
Haplo stem cell transplantation innovations are set to revolutionize cancer treatment in 2025, from personalized therapies to AI-powered diagnostics.
HAPLO STEM CELL TRANSPLANT:
A NEW HOPE
HAPLOIDENTICAL DONORS EXPLAINED
Haploidentical donors share half of their HLA markers with the patient, often being parents, siblings, or children.
EXPANDING THE DONOR POOL
Haplo transplants allow family members who are not a perfect match to donate, significantly increasing donor availability.
FIRST DEGREE RELATIVES AS IDEAL DONORS
Parents, siblings, and children are often the best haploidentical donors due to their genetic connection.
GLOBAL GROWTH OF HAPLO TRANSPLANTS
The prevalence of haploidentical transplants is increasing worldwide, supported by advancements in medical technology.
LOOK AT THE BLOG
COMPARABLE SURVIVAL RATES
Recent studies show that one-year survival rates for haploidentical transplants approach 80%, similar to fully matched transplants.
MANAGING UNIQUE COMPLICATIONS
Graft versus host disease (GVHD) is a significant risk; however, strategies like post transplant cyclophosphamide help mitigate it.
INNOVATIONS IMPROVING OUTCOMES
Innovative techniques, such as T-cell depletion and new immunosuppressive strategies, are enhancing the effectiveness of haplo transplants.
Stories
More
HOW QUICKLY DOES A LIVER TUMOR GROW?
CANCER TREATMENT BREAKTHROUGHS COMING IN 2025
See More
See More